Solasia Pharma K.K. 

€0.17
15
+€0.02+14.77% Today

Statistics

Day High
0.16
Day Low
0.16
52W High
0.24
52W Low
0.13
Volume
-
Avg. Volume
-
Mkt Cap
41.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-5.14
-3.6
-2.06
-0.52
Expected EPS
N/A
Actual EPS
N/A

Financials

-615.85%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
3.87MRevenue
-23.83MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 9SO.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. competes in the pharmaceutical sector focusing on oncology, a key area for Solasia Pharma.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. is involved in the development of cancer treatments, directly competing with Solasia's portfolio.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. focuses on innovative drug discovery in oncology, making it a direct competitor.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. has a strong presence in the development of therapeutic drugs in oncology.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. specializes in biopharmaceuticals, including cancer treatments, competing in Solasia's market space.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited focuses on pharmaceuticals, including oncology, which overlaps with Solasia Pharma's interests.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. operates in the same pharmaceutical sectors, including cancer treatment development.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Takeda Pharmaceutical Company Limited, as a large pharmaceutical company, has a diverse portfolio that includes oncology, competing with Solasia.
Sumitomo Pharma.
4506.TSE
Mkt Cap419.94B
Sumitomo Pharma Co., Ltd. is involved in creating drugs for various diseases, including cancer, making it a competitor.
Nippon Shinyaku.
4516.TSE
Mkt Cap517.95B
Nippon Shinyaku Co., Ltd. competes in the pharmaceutical market with a focus on unique and innovative cancer therapies.

About

Solasia Pharma K.K. engages in the development and marketing of oncology drugs in Japan and other Asian countries. The company offers Episil, an oral liquid for oral mucositis/stomatitis; and DARVIAS, an antineoplastic agent injection for relapsed or refractory peripheral T-cell lymphoma. It also develops Sancuso for chemotherapy induced nausea and vomiting; SP-04, which is in preclinical trial development to treat chemotherapy peripheral neuropathy; and SP-05 for the treatment of colorectal cancer. The company was founded in 2006 and is based in Tokyo, Japan.
Show more...
CEO
Mr. Yoshihiro Arai
Employees
23
Country
JP
ISIN
JP3436500007
WKN
000A2DN9S

Listings

0 Comments

Share your thoughts

FAQ

What is Solasia Pharma K.K. stock price today?
The current price of 9SO.F is €0.17 EUR — it has increased by +14.77% in the past 24 hours. Watch Solasia Pharma K.K. stock price performance more closely on the chart.
What is Solasia Pharma K.K. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Solasia Pharma K.K. stocks are traded under the ticker 9SO.F.
Is Solasia Pharma K.K. stock price growing?
9SO.F stock has risen by +11.04% compared to the previous week, the month change is a +3.64% rise, over the last year Solasia Pharma K.K. has showed a -12.31% decrease.
What is Solasia Pharma K.K. market cap?
Today Solasia Pharma K.K. has the market capitalization of 41.32M
When is the next Solasia Pharma K.K. earnings date?
Solasia Pharma K.K. is going to release the next earnings report on May 20, 2026.
What were Solasia Pharma K.K. earnings last quarter?
9SO.F earnings for the last quarter are -0 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Solasia Pharma K.K. revenue for the last year?
Solasia Pharma K.K. revenue for the last year amounts to 3.87M EUR.
What is Solasia Pharma K.K. net income for the last year?
9SO.F net income for the last year is -23.83M EUR.
How many employees does Solasia Pharma K.K. have?
As of April 02, 2026, the company has 23 employees.
In which sector is Solasia Pharma K.K. located?
Solasia Pharma K.K. operates in the Health Care sector.
When did Solasia Pharma K.K. complete a stock split?
Solasia Pharma K.K. has not had any recent stock splits.
Where is Solasia Pharma K.K. headquartered?
Solasia Pharma K.K. is headquartered in Tokyo, JP.